Got IBD? A Clinical Trial May Be Right for You

A gastroenterologist explains how patients with active inflammatory bowel disease can get early access to newer, potentially better treatments — for free.

7:00 AM

Author | Rene Wisely

Hope is on the horizon for patients with inflammatory bowel disease (IBD), a chronic condition with no cure that requires a lifetime of treatment or surgery to keep in check.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Multiple clinical trials for a variety of leading-edge medicines are underway at the University of Michigan Inflammatory Bowel Disease Program including six trials that involve drug therapies to target Crohn's disease and ulcerative colitis. Both conditions fall under the IBD umbrella.

The work might prompt IBD patients to ask themselves: Is a clinical trial right for me?

Eligibility and safety

For many, their expectation is that clinical trials are a last resort.

Most clinical trial referrals occur because patients have cycled through most or all existing treatment options and can no longer control their IBD, says gastroenterologist Peter Higgins, M.D., Ph.D., M.Sc., director of the IBD program at U-M.

"They are looking for new options," Higgins says. "A lot of times, they can skip ahead to new generations of medicines that aren't yet approved by the Food and Drug Administration or commercially available but trials are showing they can be safer, more potent and have fewer side effects."

Because clinical trials test the safety and effectiveness of new medicines, patients undergo heightened monitoring. They receive more frequent checks of their vital signs and blood chemistry, and they receive endoscopies more often than traditional IBD patients.

Another benefit: Higgins notes that patients in clinical trials tend to do better overall, which researchers attribute to the heightened care and attention.

Mutual benefits

Clinical trials also can ease a patient's financial burden. Monitoring is free and so is the medication.

SEE ALSO: Mental Health Therapy Can Help IBS, IBD Patients Manage

"These medicines may run $4,000 to $8,000 a month," Higgins says. "If that drug is helping someone to stay in remission, then it's worth it. But it's extremely helpful to get it for free."

Participants also are reimbursed for their travel expenses and parking, he adds, noting that the cost of helping others is priceless.

Because IBD affects only about 1 million people in the United States, finding volunteers for clinical trials can be difficult.

But each one brings researchers a step closer to a cure. And for many patients, clinical trials represent a fast pass to next-generation treatments. Patients can get access to new, better treatments for IBD years before they make it to market. Recently approved IBD medications like Entyvio and Stelara were available to patients in clinical trials more than five years before they were available by prescription.

"A clinical trial is often a good choice for many people with active IBD," Higgins says. "We welcome all volunteers."

To participate in an IBD clinical trial, call (734) 615-4843 or email [email protected].

More Articles About: Digestive Health Inflammatory Bowel Disease (IBD) Crohn's and Colitis Health Care Delivery, Policy and Economics Digestive (GI) Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories person holding walker with nurse next to them closer up on hands lower body
Health Lab
Long COVID happens in nursing homes, too
Post-acute sequelae of Sars-COV2 (PASC, long COVID) caused a decrease in independence and cognitive ability after coronavirus infection in nursing home residents
expert at stand hearing in suit
Health Lab
Keep telehealth alive and well, experts tell Senate subcommittee
Telehealth coverage by Medicare is scheduled to expire at the end of 2024; experts told Senators what they think should happen to preserve it.
older woman on phone with credit card in hand
Health Lab
Health plays a role in older adults' vulnerability to scams
Most older adults have faced an attempted scam, and some have been defrauded, but rates were higher among those with health problems or disabilities.
graphic drawing of colonoscopy scan with large intestine vials patient on bed doctor
Health Lab
Investment in free follow up colonoscopies will pay off
Free colonoscopies for people whose at-home stool tests (such as Cologuard and FIT) turn up signs of potential cancer are now covered by insurance, and a study shows this will save money.
Syringes in a row on yellow backfround
Health Lab
New COVID-19 vaccine a good value for U.S., U-M team finds
A cost effectiveness analysis of the updated COVID-19 vaccine shows that it will save money in older adults and give good value for other adults.
Multicolored pill bars graph chart
Health Lab
Dental opioid prescriptions still declining, but not as quickly as pre-pandemic
Dental pain treatment with opioid painkillers like Oxycontin and Oxycodone declined before and during the pandemic but the rate of decline slowed after 2020.